Investing Ideas
/
Malaysian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Malaysian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses

4 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
AHEALTH Apex Healthcare Berhad	RM 2.38	-2.9%	-17.6%	RM 1.7b	RM 2.89	PE20.6x	E11.5%	10.9%
RHONEMA Rhone Ma Holdings Berhad	RM 0.67	-1.5%	-1.5%	RM 148.2m	RM 0.70	PE11.9x	E5.8%	1.5%
KOTRA Kotra Industries Berhad	RM 4.36	4.1%	-9.0%	RM 646.6m	RM 5.37	PE15.9x	E15.6%	5.8%
MGRC Malaysian Genomics Resource Centre Berhad	RM 0.31	-8.8%	-30.3%	RM 42.5m	n/a	PS4.8x	n/a	0%

Page 1 of 1